🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the corporations hid alleged dangers that the drug presented to pediatric cognitive development.

The court filing arrives a month after Donald Trump promoted an unsubstantiated connection between using acetaminophen - also known as acetaminophen - during pregnancy and autism in young ones.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever approved for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he said they "misled consumers by making money from discomfort and pushing pills ignoring the risks."

The company states there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations lied for decades, knowingly endangering countless individuals to increase profits," the attorney general, from the Republican party, said.

The company said in a statement that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the possible consequences that could have on the health of American women and children."

On its website, the company also mentioned it had "consistently assessed the applicable studies and there is no credible data that demonstrates a established connection between using paracetamol and autism."

Organizations acting on behalf of doctors and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in Tylenol - is one of the few options for expectant mothers to manage pain and fever, which can present serious health risks if left untreated.

"In over twenty years of investigation on the use of paracetamol in gestation, not a single reputable study has definitively established that the consumption of acetaminophen in any trimester of pregnancy results in neurological conditions in offspring," the association stated.

The lawsuit references recent announcements from the Trump administration in claiming the medication is potentially dangerous.

Last month, the former president raised alarms from medical authorities when he advised women during pregnancy to "fight like hell" not to consume acetaminophen when sick.

Federal regulators then released a statement that physicians should think about restricting the consumption of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in young ones has not been established.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would identify the origin of autism in a short period.

But authorities warned that finding a single cause of autism - thought by researchers to be the consequence of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that influences how people experience and engage with the world, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is running for federal office - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism.

The lawsuit seeks to make the corporations "eliminate any promotional materials" that states acetaminophen is secure for expectant mothers.

The court case echoes the grievances of a group of parents of young ones with autism and ADHD who took legal action against the producers of Tylenol in 2022.

Judicial authorities rejected the lawsuit, declaring studies from the plaintiffs' authorities was not conclusive.